Clinical value of ACR O-RADS combined with CA125 in the risk stratification of adnexal masses
The combined model integrating O-RADS subclassification with CA125 could improve the specificity and PPV in diagnosing malignant AMs. It could be a valuable tool in the clinical application of risk stratification of AMs.
Authors
- Shuqin Zhang (ORCID: https://orcid.org/0000-0001-8223-844X)
- Bo Zhang (ORCID: https://orcid.org/0000-0001-6254-9259)
- Xin‐Wu Cui (ORCID: https://orcid.org/0000-0003-3890-6660)
- Xian‐Ya Zhang
- Ming Yu (ORCID: https://orcid.org/0000-0002-3462-3754)
- Ran Li (ORCID: https://orcid.org/0000-0003-2794-9948)
- Ruike Pan
- Tong Xu
Institutions
- First Affiliated Hospital of Xinxiang Medical University (CN)
- Shanghai East Hospital (CN)
- The First People’s Hospital of Lianyungang (CN)
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
- Henan Medical University (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-08-30
- DOI
- https://doi.org/10.3389/fonc.2024.1369900
- Citations
- 1
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.54